Proton beam therapy has been called “the next great leap forward in radiation oncology” and “the most technologically-advanced method of treating solid, non-metastasized tumors.” For many patients, proton therapy offers them hope for the first time. Yet, due to cost and complexity, it has remained a rare treatment option, with only nine proton beam therapy centers in the United States.
Starting in December of 2012, McLaren will improve those treatment options for patients in Michigan and surrounding areas by opening the first…and only…Proton Therapy Center in Michigan.
McLaren chose to make the $65 million investment in this technology after intense research and investigation into the value of treatment for patients. This research led to a partnership with ProTom International, a Texas-based health care technology company which has developed the latest generation of proton therapy. Called the Radiance 330, this advanced technology offers even better clinical outcomes. Upon its opening late in 2012, the McLaren facility will initially be the only facility in the world with this specialized functionality.